PETER ROST: PHARMA MARKETING EXPERT WITNESS. AWP, MEDICAL DEVICE EXPERT.: To write or not to write, that is the question.

Dr. Rost provides services as a pharmaceutical marketing expert witness. For more info see: Drug Expert Witness. Dr. Peter Rost email. Copyright © 2006-2013 InSync Communication. All rights reserved. Terms of use agreement, privacy policy and the computer fraud and abuse act.


Peter Rost, M.D., is a former Pfizer Marketing Vice President providing services as a medical device and drug expert witness and pharmaceutical marketing expert. Judge Sanders: "The court agrees with defendants' view that Dr. Rost is a very adept and seasoned expert witness." He is also the author of Emergency Surgery, The Whistleblower and Killer Drug. You can reach him on rostpeter (insert symbol) Please read the terms of use agreement and privacy policy for this blog carefully.

To write or not to write, that is the question.

PharmaBlogReview had an interesting piece, reviewing the most interesting pharma blogs here.

The Pharma Law blog made the list, and Christiane Truelove wrote the following:

"The Pharma Law Blog Former Pfizer whistleblower Dr. Peter Rost continues blogging, but seems to have lost some steam. Still, you never know when he’ll bring to light another scandal. And now that he’s working as an expert for plaintiffs’ lawyers in pharmaceutical industry cases, maybe he’ll get a bit more to talk about."

And that made me think about blogging or not and what to write about.

Quite frankly, writing day in and day out about pharma news is a bit boring to me, and contrary to PharmaBlogReview's suggestion, to write or talk about companies that are involved in litigation in which I'm involved as an expert witness is dicey.

Being an expert witness means that suddenly I know more than ever about all kinds of buried bodies, but the material from which I learned this is often confidential, and so I won't ever be able to discuss such things.

I realize that certain expert witnesses seem to assist in distributing material they've received during their professional work, but I don't think that is a good idea.

So, that means the Pharma Law Blog has been a bit more silent on corporate malfeasance than usual.

The interesting part is that it doesn't seem to make any difference what I write; visitors keep coming anyway. That is a bit bewildering for a marketing guy such as myself, but hey, it means that I can just hang out here now and then.

Feel free to come and do the same!


Post a Comment

Links to this post:

Create a Link

<< Home